Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A reTrOspective Study on Patient's Data From the French Cemiplimab Cohort ATU Programs Compared to Standard of Care in France

NCT05302297 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT05302297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05302297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A reTrOspective Study on Patient's Data From the French Cemiplimab Cohort ATU Programs Compared to Standard of Care in France
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
January 17, 2022
Completion date
September 30, 2022
Enrollment
305 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer/squamous cell carcinoma of skin